Published in Transfusion on March 31, 2009
Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci (2010) 1.78
Red blood cell storage: the story so far. Blood Transfus (2010) 1.46
Time-course investigation of SAGM-stored leukocyte-filtered red bood cell concentrates: from metabolism to proteomics. Haematologica (2011) 1.44
Relationship between red cell storage duration and outcomes in adults receiving red cell transfusions: a systematic review. Crit Care (2013) 1.01
Red blood cell storage in SAGM and AS3: a comparison through the membrane two-dimensional electrophoresis proteome. Blood Transfus (2012) 1.00
Does prolonged storage of red blood cells cause harm? Br J Haematol (2014) 0.97
Does red blood cell storage affect clinical outcome? When in doubt, do the experiment. Transfusion (2009) 0.93
Transfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cells. Transfusion (2011) 0.93
Red blood cell subpopulations in freshly drawn blood: application of proteomics and metabolomics to a decades-long biological issue. Blood Transfus (2012) 0.88
Getting it right: optimizing transfusion management during the procedure. J Extra Corpor Technol (2009) 0.75
Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg (2007) 5.32
2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg (2011) 4.84
Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet (2003) 4.21
Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med (2004) 3.94
Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher (2010) 3.47
Policy: Sustainable development goals for people and planet. Nature (2013) 3.39
Retracted The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg (2006) 3.15
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells. AIDS (2008) 2.87
The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg (2003) 2.46
Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery. J Thorac Cardiovasc Surg (2003) 2.25
Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery. Anesthesiology (2005) 2.22
Periventricular leukomalacia is common after neonatal cardiac surgery. J Thorac Cardiovasc Surg (2004) 2.19
Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery. Stroke (2013) 2.05
UN sustainability goals need quantified targets. Nature (2014) 2.02
Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology (2002) 1.96
Novel diagnostic test for acute stroke. Stroke (2003) 1.82
Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Crit Care Med (2007) 1.81
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke (2004) 1.78
Does perioperative systolic blood pressure variability predict mortality after cardiac surgery? An exploratory analysis of the ECLIPSE trials. Anesth Analg (2011) 1.77
APOE polymorphism is associated with risk of severe sepsis in surgical patients. Crit Care Med (2005) 1.70
Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. Ann Thorac Surg (2010) 1.68
Cognitive function after major noncardiac surgery, apolipoprotein E4 genotype, and biomarkers of brain injury. Anesthesiology (2010) 1.68
Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia. Crit Care Med (2005) 1.66
The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med (2008) 1.66
In utero or ex utero cord blood collection: which is better? Transfusion (2002) 1.64
Efficacy of single-dose, multilevel paravertebral nerve blockade for analgesia after thoracoscopic procedures. Anesthesiology (2006) 1.61
Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol (2002) 1.60
Utility of a simple algorithm to grade diastolic dysfunction and predict outcome after coronary artery bypass graft surgery. Ann Thorac Surg (2011) 1.58
Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG. Ann Thorac Surg (2004) 1.54
The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg (2008) 1.54
Platelet Counts, Acute Kidney Injury, and Mortality after Coronary Artery Bypass Grafting Surgery. Anesthesiology (2016) 1.51
Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med (2006) 1.51
Transcranial Doppler emboli count predicts rise in creatinine after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth (2004) 1.50
Postoperative hyperthermia following off-pump versus on-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth (2005) 1.48
Storage age of transfused platelets and outcomes after cardiac surgery. Transfusion (2010) 1.46
Predictors of inotrope use during separation from cardiopulmonary bypass. J Cardiothorac Vasc Anesth (2004) 1.44
Aortic atheroma burden and cognitive dysfunction after coronary artery bypass graft surgery. Ann Thorac Surg (2004) 1.43
Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery. Can J Anaesth (2007) 1.43
Cerebral physiology of cardiac surgical patients treated with the perfluorocarbon emulsion, AF0144. Ann Thorac Surg (2005) 1.42
Serum creatinine patterns in coronary bypass surgery patients with and without postoperative cognitive dysfunction. Anesth Analg (2002) 1.41
Hurry up and slow down: lessons in drug development from the COX-2 inhibitors. Can J Anaesth (2006) 1.40
Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients. Ann Thorac Surg (2006) 1.39
Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher (2007) 1.38
Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery. J Am Coll Cardiol (2007) 1.27
The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg (2002) 1.24
High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass. Blood (2013) 1.16
The association of complication type with mortality and prolonged stay after cardiac surgery with cardiopulmonary bypass. Anesth Analg (2002) 1.12
Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks. Biol Blood Marrow Transplant (2004) 1.10
Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. Stroke (2002) 1.10
Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg (2010) 1.09
Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis (2005) 1.08
Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA (2004) 1.07
The association of postcardiac surgery acute kidney injury with intraoperative systolic blood pressure hypotension. Anesthesiol Res Pract (2013) 1.07
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost (2012) 1.06
Intraoperative hyperglycemia and cognitive decline after CABG. Ann Thorac Surg (2007) 1.06
A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth Analg (2007) 1.05
The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg (2002) 1.05
Deterioration of regional wall motion immediately after coronary artery bypass graft surgery is associated with long-term major adverse cardiac events. Anesthesiology (2007) 1.05
Effects of extreme hemodilution during cardiac surgery on cognitive function in the elderly. Anesthesiology (2007) 1.04
Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. Stroke (2009) 1.02
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl (2009) 1.00
Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage. J Clin Neurosci (2012) 0.99
Female gender is associated with impaired quality of life 1 year after coronary artery bypass surgery. Psychosom Med (2003) 0.97
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol (2007) 0.97
Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery. Psychosom Med (2008) 0.96
Genetic polymorphisms and the risk of stroke after cardiac surgery. Stroke (2005) 0.96
Intraoperative systolic blood pressure variability predicts 30-day mortality in aortocoronary bypass surgery patients. Anesthesiology (2010) 0.95
Novel human alpha1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.95
Protecting the brain in coronary artery bypass graft surgery. JAMA (2002) 0.94
Enhancement of anti-tumor immunity through local modulation of CTLA-4 and GITR by dendritic cells. Eur J Immunol (2011) 0.94
Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses. Circulation (2011) 0.93
Impact of transfusion of autologous 7- versus 42-day-old AS-3 red blood cells on tissue oxygenation and the microcirculation in healthy volunteers. Transfusion (2012) 0.92
Iliohypogastric-ilioinguinal peripheral nerve block for post-Cesarean delivery analgesia decreases morphine use but not opioid-related side effects. Can J Anaesth (2002) 0.92